PPIST07430
Protein Information
| Protein_Chain | C[auth L]/A[auth H] |
|---|---|
| Protein_Sequence | ADCGLRPLFEKKSLEDKTERELLESYI/IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQF |
Peptide Information
| Peptide_Chain | B[auth I] |
|---|---|
| Peptide_Sequence | DFEEIPEEYL |
| Peptide_Length | 10 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 4LOY |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.77 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | 5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor. |
|---|---|
| Release_Year | 2013 |
| PMID | 24175584 |
| DOI | 10.1021/jm4005835 |